| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |